|Year : 2015 | Volume
| Issue : 1 | Page : 20-23
Value of past clinical history in differentiating bronchial asthma from COPD in male smokers presenting with SOB and fixed airway obstruction
Prahlad Rai Gupta, Anupam, Ashok Kumar Mehrotra, Trilok Kumar Khublani, Shradha Soni, Asif Feroz
Department of Respiratory Medicine, NIMS Medical College and Hospital, Jaipur, Rajasthan, India
|Date of Web Publication||2-Jan-2015|
Dr. Prahlad Rai Gupta
A-66 Subhash Nagar Shopping Centre, Jaipur - 302 016, Rajasthan
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Objective: Differentiating asthma from chronic obstructive pulmonary disease (COPD) is difficult. Steroid trial may be of help but has several pitfalls. The present study aims to assess the value of past clinical profile of asthma and its differential diagnosis from COPD in male smokers and thereby to formulate clinical parameters to diagnose bronchial asthma in such patients. Patients and Methods: Male smokers who reported at the Respiratory Medicine Department of the National Institute of Medical Sciences (NIMS) Hospital, Jaipur, (India), with shortness of breath (SOB) and showing less than 12% postbronchodilator bronchial reversibility (BR) on spirometry were recruited. These patients were given oral prednisolone 1 mg/kg for two weeks. Post steroid (PS) spirometry was performed to ascertain BR. The past clinical history was recorded and analyzed to determine if it is of any use in differentiating asthma from COPD. Result: Out of 104 patients, four were lost to follow up, 52 were diagnosed as bronchial asthma, and the remaining 48 as COPD. It was revealed that past history of (H/O) seasonal variation, wheezing, eye allergy, nasal allergy, dust allergy, skin allergy, and family H/O asthma/allergy were positive in 50, 40, 34, 30, 18, 14, and 12 asthma patients as compared to 10, 8, 2, 4, 6, 0, and 0 in 48 COPD patients (P < 0.001). The odds ratio (OR) for diagnosing asthma was highest for the presence of any other two symptoms/variables, besides SOB, in the past (OR = 275, P < 0.0001). Conclusion: Past clinical history is of immense value in differentiating asthma from COPD in male smokers presenting with SOB and fixed airway obstruction.
Keywords: Asthma, chronic obstructive pulmonary disease, smoker
|How to cite this article:|
Gupta PR, Anupam, Mehrotra AK, Khublani TK, Soni S, Feroz A. Value of past clinical history in differentiating bronchial asthma from COPD in male smokers presenting with SOB and fixed airway obstruction. Lung India 2015;32:20-3
|How to cite this URL:|
Gupta PR, Anupam, Mehrotra AK, Khublani TK, Soni S, Feroz A. Value of past clinical history in differentiating bronchial asthma from COPD in male smokers presenting with SOB and fixed airway obstruction. Lung India [serial online] 2015 [cited 2019 Oct 21];32:20-3. Available from: http://www.lungindia.com/text.asp?2015/32/1/20/148432
| Introduction|| |
Tobacco smoke, an established risk factor for chronic obstructive pulmonary disease (COPD), is now being increasingly incriminated in the pathogenesis of bronchial asthma also. In most developed countries, ~25% of adults with asthma are current cigarette smokers.  Such asthma patients often present with shortness of breath (SOB) and cough, with or without sputum production, and a fixed or partially reversible airflow obstruction, a clinical scenario that is similar to COPD.  Even the typical pathological characterization of asthma is lost in smokers. As a result, these patients are being treated with therapies that target both asthma and COPD rather than one of these diseases, resulting in poor outcome.
Traditionally, steroid trial has been used to differentiate asthma and COPD. In steroid trial, fixed airflow limitation is considered as diagnostic of COPD but a positive response to steroid trial favors the diagnosis of asthma.  Steroid trial, however, has certain drawbacks i.e., many of these patients are lost to follow up, the results of steroid trial are not 100% specific, and undesirable side effects of oral steroids are common even during the short course of steroids  thus limiting its usefulness in differentiating asthma from COPD.
It is widely accepted that asthma and COPD pursue a different natural history. Therefore, it was hypothesized that the past clinical history may typically continue to guide the diagnosis of asthma in smokers who are now presenting with a clinicophysiological scenario similar to that of COPD, in spite of the smoke-related alterations. The current study aims to analyze the value of past history, more particularly the history of respiratory and nonrespiratory allergies, in distinguishing smoker asthma patients from COPD. No such study has ever been done in the past to the best of our knowledge.
| Patients and Methods|| |
The intake of patients for the study started in July 2012 and ended in Aug 2013, comprising all male smoker patients above the age of 18 years who presented with SOB at the outpatient section of the Department of Respiratory Medicine. The protocol of the study was approved by the Scientific Committee, National Institute Medical Sciences, Jaipur (India) vide its order number 02, dated 18.08.2012.
These initially recruited patients were clinically reevaluated with regard to symptoms, smoking history, and physical findings and then subjected to routine investigations, namely, sputum smear examination by Ziehl-Nelson method, blood examination for hemoglobin, total leukocyte count (TLC), differential leukocyte count, total eosinophil count (TEC), fasting sugar, liver function tests, human immunodeficiency virus antibodies; urine for complete examination and electrocardiography. Patients having disease/s other than asthma/COPD and those having coexisting hypertension, diabetes mellitus, and cardiac, hepatic or renal diseases were excluded. The remaining patients were subjected to spirometry (RMS Helios 401). Bronchial reversibility (BR) was assessed by repeating spirometry, 15 min postinhalation of bronchodilator (B, 200 μg salbutamol) with the help of a jet nebulizer. Percentage reversibility was calculated as:-
%BR = Post B FEV 1 - Pre B FEV 1 /Pre B FEV 1 × 100
Reversible airway obstruction was defined as >12% increase in Forced Expiratory Volume in 1 second (FEV1) (or FEV1/forced vital capacity (FVC)), postbronchodilator (B). 
All the patients who showed fixed airway obstruction (post B FEV 1 /FVC ratio less than 70% with less than 12% reversibility of FEV 1 ), except those who were unwilling to remain under follow up, were finally recruited in this study. These patients were interviewed in detail with regard to the presence of a symptom/group of symptoms or a variable, suggestive of respiratory and nonrespiratory allergies in the past i.e., wheeze, chest tightness, seasonal variation, dust allergy, eye allergy (redness, itching, watering), nasal allergy (running nose, nasal stuffiness, sneezing) or skin allergy (rashes, itching, eczema) in self or in his family members. The patients were then put on oral prednisolone (1 mg/kg body weight) for 14 days but were asked not to use any bronchodilator or inhaled steroid during this period. After two weeks, spirometry was repeated to reassess poststeroid (PS) FEV 1 and FEV 1 /FVC). Those having reversible airflow obstruction were diagnosed as bronchial asthma and the remaining, with nonreversible airflow obstruction, as COPD. 
All continuous variables were analyzed as the mean ± SD and compared using student's t test. Chi-square test was used to compare the noncontinuous variables. A two-sided P value less than 0.05 was considered statistically significant. Variables whose correlation coefficient were less than 0.800 were also tested on SPSS version 17.0 program for Windows (SPSS Inc., Chicago, IL, USA) for multivariate analysis.
A total of 104 patients could be recruited during the study period. Out of these, four patients did not present themselves for follow up and were excluded. This left 100 patients for analysis. PS, 52 (out of the 100 patients) were diagnosed as bronchial asthma and the remaining 48 as COPD. [Table 1] summarizes the basic parameters of these patients. Although there was no difference in the mean age of the patients, symptoms, TLC, and pre and post B FEV 1 and FEV 1 /FVC ratio in the two groups (P > 0.05), the mean body mass index (BMI), TEC, and mean FVC were significantly higher in the asthma group (P < 0.05).
[Table 2] shows the correlation between different symptoms/variables in the past history in the two groups. A positive past history of skin allergy in self or family history of allergy/asthma was found only in asthma patients but it lacked sensitivity (26.9 and 23%, respectively). Highest odds ratio (OR) for any single variable was observed when the diagnosis of asthma was based on the positive past history of seasonal variation (p < 0.0001), but the OR for diagnosis of asthma was highest with the presence of any two symptoms/variables in the past history [Table 3]. The OR for diagnosis of asthma was also high with the presence of seasonal variation along with any other variable in the past history [Table 4].
|Table 2: Distribution of patients according to positive past history of symptoms/variables suggestive of asthma|
Click here to view
|Table 3: Distribution of patients according to number of symptoms/parameters in the past history|
Click here to view
|Table 4: Distribution of patients according to positive history of seasonal variation with any other symptoms/ variables S/O asthma|
Click here to view
As the highest OR for diagnosis of asthma was achieved with the positive history of any two variables in the past history, it was correlated to the results of steroid trial [Table 5]. The diagnostic accuracy of the diagnosis of asthma based on presence of any two symptoms/variables in the past history was 98%.
|Table 5: Correlation between steroid trial and positive history of any 2 symptoms S/O asthma in the past|
Click here to view
| Discussion|| |
There was no difference in asthma and COPD patients with respect to age, symptoms, TLC, FEV1/FVC ratio, and pre B FEV1 and post B FEV (P > 0.05). The mean BMI, TEC, and FVC values were marginally higher in asthma patients. More COPD patients in our study were current smokers as compared to asthma (36 V/S 26, P < 0.011). Melbye et al.  also reported similarly. More asthma patients were predominantly hukka smokers as compared to other types of smoking, but bidi smoking was more prevalent in COPD patients. Gupta and Mangal  have also reported high correlation between hukka smoking and asthma diagnosis. This difference could be because of difference in quantity and/or quality of particulate matter or chemical composition of smoke generated during hukka and bidi smoking and is a subject for further research.
The natural history of asthma is known to be characterized by typical symptoms and/or allergy diathesis. Bousquet et al.  observed that wheeze, SOB, and chest tightness were common symptoms in asthma. Sistek et al.  reported 75% sensitivity for wheezing alone and 80%, for cough and chest tightness. Nystad et al.  and Zedan et al.  reported wheezing and chest tightness in majority of their asthma patients. Melbye et al.  Grossman  and Wallace et al.  reported coexisting asthma and allergic rhinitis in 28 - 78% of their asthmatics. Martinez  and Dodge et al.  reported that wheezing was common in early life in patients who developed asthma later on. Khaled et al.  reported that wheeze, eye allergy, and eczema were the three main symptoms in past history of the patients who developed asthma later on. Roorda et al.  and Reed et al.  have found positive association between asthma and family history of asthma, eczema, and allergic rhinitis. Faniran et al.,  Terreehorst et al.,  Aggarwal et al.  and Gupta and Mangal  reported significant association of asthma with atopy to dust. Burke et al.,  Aggarwal et al.  and Gupta and Mangal  reported higher prevalence of family history in bronchial asthma ranging from 2 to 26%. But none has used past history of asthma-related symptoms/variables in the differential diagnosis of asthma and COPD in smokers.
In this study, past history of wheeze (77%), chest tightness (54%), seasonal variation (96%), and/or nonrespiratory (eye, nasal, skin and/or dust) allergy were more common in asthma patients as compared to COPD. Skin allergy and family history of asthma/allergy were found only in asthma patients but it lacked sensitivity. The OR for these symptoms to differentiate asthma from COPD was 16.6 for wheeze, 26.83 for chest tightness, 75.0 for seasonal variation, 43.44 for eye allergy, 15.0 for nasal allergy, and 3.70 for dust allergy in this study. Taking a single symptom in the past history for diagnosing asthma, the highest OR was found for seasonal variation. However, when any two of the above symptoms were taken together, the OR increased to 275.0, although it was lowered to 126.5 when any three of the above symptoms were taken together because of loss of sensitivity. Diagnosis of asthma made on the basis of symptoms/variables in the past history was tested by correlating it to the results of steroid trial. The Pearson correlation coefficient was 53.6, 77.49, and 65.03 for any one, any two, and any three symptoms/variables in the past history, respectively, and the diagnostic accuracy was 98% for the presence of any two symptoms/variables. Based on this, it can be easily inferred that the presence of any two of the asthma-related symptoms/variables in the past history is a valuable tool in differential diagnosis of asthma from COPD in smokers presenting with SOB.
| References|| |
Thomson NC, ChaudhuriR, Livingston E. Asthma and cigarette smoking. EurRespir J 2004;24:822-33.
Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The Asthma-COPD overlap syndrome: A common clinical problem in the elderly. JAllergy (Cairo) 2011;2011:861926.
Chapman S, Robinson G. Asthma: Investigations. In: Chapman S, Robinson G, Stradling J, West S, editors. Oxford Handbook of Respiratory Medicine. 2 nd
ed. UK: Oxford University Press; 2009. p. 126-7.
Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al
. Interpretative strategies for lung function tests. EurRespir J 2005;26:948-68.
Melbye H, Drivenes E, Dalbak LG, LeinanT, Høegh-Henrichsen S, Ostrem A. Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more. Int J Chron Obstruct Pulmon Dis 2011;6:597-603.
Gupta PR, Mangal DK. Prevalence and risk factors for bronchial asthma in adults in Jaipur district of Rajasthan (India). Lung India 2006;23:53-8.
Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma.Frombronchoconstriction to airways inﬂammation and remodeling. Am J RespirCrit Care Med 2000;161:1720-45.
Sistek D, Tschopp JM, Schindler C, Brutsche M, Ackermann-Liebrich U, Perruchoud AP, et al
. Clinical diagnosis of current asthma: Predicted value of respiratory symptoms in the SAPALDIA study. Swiss Study on air pollution and lung diseases in adults. EurRespir J 2001;17:214-9.
Nystad W, Meyer HE, Nafstad P, Tverdal A, Engeland A. Body mass index in relation to adult asthma among 135,000 Norwegian men and women. AmJEpidemiol2004;160:969-76.
Zedan M, SettinA, Farag M, Ezz-Elregal M, Osman E, Fouda A. Prevalence of bronchial asthma among Egyptian school children. EgyptJBronchol2009;3:124-30.
Grossman J. One airway, one disease. Chest 1997;111 Suppl 2 :11S-6S.
Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al
. Joint Task Force onPractice; American Academy of Allergy; Asthma and Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy ClinImmunol 2008;122 Suppl 2 :S1-84.
Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8.
Dodge R, Martinez FD, Cline MG, Lebowitz MD, Burrows B. Early childhood respiratory symptoms and the subsequent diagnosis of asthma. J Allergy ClinImmunol 1996;98:48-54.
Ait-Khaled N, Odhiambo J, Pearce N, Adjoh KS, Maesano IA, Benhabyles B, et al
. Prevalence of symptoms of asthma, rhinitis andeczema in 13- to 14-year-old children in Africa: The International Study of Asthma and Allergies in Childhood Phase III. Allergy 2007;62:247-58.
Roorda RJ. Prognostic factors for the outcome of childhood asthma in adolescence. Thorax 1996;51 Suppl 1 :S7-12.
Reed CE. The natural history of asthma in adults: The problem of irreversibility. J Allergy ClinImmunol 1999;103:539-47.
Faniran AO, Peat JK, Woolcock AJ. Prevalence of atopy, asthma symptoms and diagnosis, and the management of asthma: Comparison of an affluent and a non-affluent country.Thorax 1999;54:606-10.
Terreehorst I, Oosting AJ, Tempels-PavlicaZ, de Monchy JG, Bruijnzeel-Koomen CA, Hak E, et al
. Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. ClinExp Allergy 2002;32:1160-5.
Aggarwal AN, Chaudhry K, Chhabra SK, D′Souza GA, Gupta D, Jindal SK, et al
. AsthmaEpidemiology Study Group. Prevalence and risk factors forbronchial asthma in Indian adults: A multicentre study. Indian J Chest Dis Allied Sci 2006;48:13-22.
Burke W, Fesinmeyer M, Reed K, Hampson L, Carlsten C. Family history as a predictor of asthma risk. Am J Prev Med 2003;24:160-9.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]